BioPharm America 2012

Beginning its fifth year as an industry event, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.

It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.

The backdrop for this intensive business development activity is a three-day conference program that features leading executives from across the life science industry. At BioPharm America held in Boston in September 2011, panel discussions included licensing, investment and business development executives from Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Genentech, Genzyme, Gilead, Ironwood, Janssen Global Services, Merck, Nycomed, Pfizer, and Shire. The event attracted 950+ delegates from 588 companies who participated in 2,550+ scheduled one-to-one meetings.

For information about the BioPharm America 2012 program and registration information, please register your email address for regular updates from EBD Group at update@ebdgroup.com.

Contact:
Christina Hundschell
EBD Group, Inc.
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 930 0520
chundschell@ebdgroup.com

Website:
www.ebdgroup.com/bpa

Industry:
Biotech

Key words:
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance

Intended For:
Top international executives from:
§ Established and emerging biotech companies
§ Pharmaceutical companies
§ Institutional financial firms
§ Private investors including venture capital and private equity firms